HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atrial Remodeling Following Catheter Ablation for Atrial Fibrillation-Mediated Cardiomyopathy: Long-Term Follow-Up of CAMERA-MRI Study.

AbstractOBJECTIVES:
This study sought to determine the long-term right atrial (RA) electrical and structural changes in a subgroup from the CAMERA-MRI (Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction-Magnetic Resonance Imaging) study.
BACKGROUND:
Catheter ablation (CA) is successful in restoring ventricular function in patients with atrial fibrillation (AF) and otherwise unexplained cardiomyopathy, as demonstrated in the randomized study of CA versus rate control (CAMERA-MRI). It is unknown if this is associated with atrial remodeling.
METHODS:
Detailed electroanatomical (EA) mapping of the RA using CARTO3 and a force sensing catheter was performed at initial CA and electively at least 12 months after CA in patients with >90% reduction in AF burden following ablation. Bipolar voltage, fractionation, and conduction velocity were collected in 4 segments together with echo and cardiac magnetic resonance imaging.
RESULTS:
Fifteen patients (mean age 59.1 ± 6.8 years) underwent repeat RA EA mapping. At a mean follow-up of 23.4 ± 11.9 months, left ventricular (LV) ejection fraction improved from 33.6 ± 3.2% to 54.1 ± 3.2% (p = 0.001), RA area decreased from 28.4 ± 2.0 cm2 to 20.8 ± 1.2 cm2 (p < 0.001), and left atrial area decreased from 32.9 ± 2.3 cm2 to 26.8 ± 1.4 cm2 (p = 0.007). On EA mapping, RA bipolar voltage increased from 1.6 ± 0.1 mV to 1.9 ± 0.1 mV (p = 0.04). Tissue voltage increased across all regions, which achieved statistical significance at the posterior (p = 0.002) and septal (p = 0.01) segments. There was a significant decrease in complex fractionated electrograms from 21.7 ± 3.5% to 8.3 ± 1.8% (p = 0.002); however, no significant change occurred in global or regional conduction velocities (p = 0.5).
CONCLUSIONS:
Recovery of atrial electrical and structural changes was observed following restoration of sinus rhythm and recovery of LV function in patients who underwent CA for persistent AF and LV systolic dysfunction. The randomized CAMERA MRI study demonstrated significant improvement in LV systolic function with AF ablation compared with rate control. The present study demonstrated reverse electrical and structural atrial recovery in concert with recovery of LV systolic function at 2 years post-AF ablation. This may partially explain the long-term success of CA in patients with AF and otherwise unexplained cardiomyopathy.
AuthorsHariharan Sugumar, Sandeep Prabhu, Aleksandr Voskoboinik, Shane Young, Sarah J Gutman, Geoffrey R Wong, Ramanathan Parameswaran, Chrishan J Nalliah, Geoff Lee, Alex J McLellan, Andrew J Taylor, Liang-Han Ling, Jonathan M Kalman, Peter M Kistler
JournalJACC. Clinical electrophysiology (JACC Clin Electrophysiol) Vol. 5 Issue 6 Pg. 681-688 (06 2019) ISSN: 2405-5018 [Electronic] United States
PMID31221354 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Atrial Fibrillation (complications, surgery)
  • Atrial Remodeling
  • Cardiomyopathies (diagnostic imaging, etiology, physiopathology)
  • Catheter Ablation
  • Echocardiography
  • Electrophysiologic Techniques, Cardiac
  • Female
  • Heart Atria (diagnostic imaging, physiopathology)
  • Heart Conduction System (physiopathology)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Stroke Volume
  • Treatment Outcome
  • Ventricular Dysfunction, Left (diagnostic imaging, etiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: